Monoclonal antibody therapy

Monoclonal Antibody Therapy

Diagram of an antibody, showing the variable and constant regions.

Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAbs) to bind specifically to certain cells or proteins. The objective is to stimulate the patient's immune system to attack those cells. It is a type of targeted therapy, which means it targets specific molecules involved in the growth and spread of cancer cells.

Mechanism of Action

Monoclonal antibodies are designed to recognize and bind to specific antigens, which are unique proteins on the surface of cells. Once bound, these antibodies can:

• Block cell growth: By binding to the antigens, mAbs can block the signals that promote cell growth.
• Mark cells for destruction: The immune system can recognize the bound antibodies and destroy the marked cells.
• Deliver radiation or chemotherapy: Some mAbs are conjugated with radioactive particles or chemotherapy drugs, delivering these agents directly to the cancer cells.

Types of Monoclonal Antibodies

Monoclonal antibodies can be classified based on their source and structure:

• Murine antibodies: Derived from mouse proteins, these can cause immune reactions in humans.
• Chimeric antibodies: Contain both human and mouse components, reducing the likelihood of an immune response.
• Humanized antibodies: Mostly human, with only a small part derived from mouse proteins.
• Fully human antibodies: Entirely human, minimizing the risk of immune reactions.

Applications in Medicine

Monoclonal antibody therapy is used in the treatment of various diseases, including:

• Cancer: mAbs can target specific cancer cell antigens, such as HER2 in breast cancer or CD20 in non-Hodgkin lymphoma.
• Autoimmune diseases: Conditions like rheumatoid arthritis and multiple sclerosis can be treated with mAbs that target specific immune cells or cytokines.
• Infectious diseases: mAbs can neutralize pathogens or their toxins, as seen in treatments for COVID-19.

Advantages and Limitations

Advantages

• Specificity: mAbs can precisely target diseased cells, sparing healthy ones.
• Versatility: They can be engineered to carry drugs, toxins, or radioactive substances.

Limitations

• Cost: Production and development of mAbs are expensive.
• Immune reactions: Some patients may develop immune responses against the antibodies.
• Resistance: Cancer cells may develop resistance to mAb therapy over time.

Future Directions

Research is ongoing to improve the efficacy and reduce the side effects of monoclonal antibody therapy. Advances in genetic engineering and biotechnology are paving the way for the development of more effective and personalized treatments.

Related Pages

• Immunotherapy
• Targeted therapy
• Cancer treatment
• Biotechnology